Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 23-Feb-21 6:05 PM View:  | Theravance Biopharma, Inc. (TBPH) | 20-Feb-21 | Payment of Exercise | 35,672 | $18.79 | $670,277.00 | (13%) 278.17K to 242.5K | 4% |
| 24-Nov-20 6:16 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Nov-20 | Payment of Exercise | 4,639 | $17.21 | $79,837.20 | (2%) 282.81K to 278.17K | (9%) |
| 14-Oct-20 4:15 PM View: | Aimmune Therapeutics, Inc. (AIMT) | 13-Oct-20 | Disposition | 13,313 | $34.50 | $459,298.00 | (100%) 13.31K to 0 | |
| 14-Oct-20 4:15 PM View: | Aimmune Therapeutics, Inc. (AIMT) | 10-Oct-20 | Disposition (change in control) | 6,250 | $34.50 | $215,625.00 | (100%) 6.25K to 0 | |
| 24-Aug-20 6:21 PM View: | Theravance Biopharma, Inc. (TBPH) | 21-Aug-20 | Market Sale | 25,000 | $18.29 | $457,240.00 | (8%) 307.81K to 282.81K | (2%) |
| 24-Aug-20 6:21 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Aug-20 | Payment of Exercise | 4,646 | $18.22 | $84,650.10 | (1%) 312.46K to 307.81K | (3%) |
| 29-May-20 7:17 PM View: | Aimmune Therapeutics, Inc. (AIMT) | 27-May-20 | Grant | 13,313 | -- | -- | 213% 6.25K to 19.56K | |
| 22-May-20 6:06 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-May-20 | Payment of Exercise | 4,212 | $26.67 | $112,334.00 | (1%) 316.67K to 312.46K | 30% |
| 24-Feb-20 7:07 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Feb-20 | Payment of Exercise | 33,608 | $25.90 | $870,447.00 | (10%) 350.28K to 316.67K | 28% |
| 05-Feb-20 6:57 PM View: | Theravance Biopharma, Inc. (TBPH) | 03-Feb-20 | Grant | 119,000 | -- | -- | 51% 231.28K to 350.28K | |
| 22-Nov-19 6:20 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Nov-19 | Payment of Exercise | 2,692 | $17.60 | $47,379.20 | (1%) 233.97K to 231.28K | (7%) |
| 22-Aug-19 6:00 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Aug-19 | Payment of Exercise | 2,710 | $21.51 | $58,292.10 | (1%) 236.68K to 233.97K | 13% |
| 22-May-19 6:05 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-May-19 | Payment of Exercise | 2,705 | $19.84 | $53,667.20 | (1%) 239.38K to 236.68K | 5% |
| 22-Feb-19 6:13 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Feb-19 | Payment of Exercise | 7,778 | $27.00 | $210,006.00 | (3%) 247.16K to 239.38K | 31% |
| 07-Feb-19 5:43 PM View: | Theravance Biopharma, Inc. (TBPH) | 05-Feb-19 | Grant | 112,250 | -- | -- | 34% 334.82K to 447.07K | |
| 21-Nov-18 5:43 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Nov-18 | Payment of Exercise | 7,368 | $24.79 | $182,653.00 | (5%) 142.28K to 134.91K | |
| 22-Aug-18 7:33 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Aug-18 | Payment of Exercise | 6,683 | $26.95 | $180,107.00 | (4%) 148.96K to 142.28K | |
| 22-May-18 7:01 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-May-18 | Payment of Exercise | 26,991 | $24.31 | $656,151.00 | (15%) 175.95K to 148.96K | |
| 16-May-18 7:03 PM View: | Theravance Biopharma, Inc. (TBPH) | 14-May-18 | Grant | 33,750 | -- | -- | 24% 142.2K to 175.95K | |
| 22-Feb-18 5:39 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Feb-18 | Payment of Exercise | 8,293 | $29.09 | $241,243.00 | (6%) 150.5K to 142.2K | |
| 14-Feb-18 6:20 PM View: | Theravance Biopharma, Inc. (TBPH) | 12-Feb-18 | Grant | 9,000 | -- | -- | 6% 141.5K to 150.5K | |
| 22-Nov-17 4:37 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Nov-17 | Payment of Exercise | 7,846 | $28.58 | $224,239.00 | (5%) 149.34K to 141.5K | |
| 22-Aug-17 6:28 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Aug-17 | Payment of Exercise | 7,064 | $27.40 | $193,554.00 | (5%) 156.41K to 149.34K | |
| 23-May-17 7:59 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-May-17 | Payment of Exercise | 7,065 | $36.83 | $260,204.00 | (4%) 163.47K to 156.41K | |
| 08-Mar-17 6:11 PM View: | Theravance Biopharma, Inc. (TBPH) | 07-Mar-17 | Sale | 424 | $30.80 | $13,059.20 | (< 1%) 163.9K to 163.47K | |
| 08-Mar-17 6:11 PM View: | Theravance Biopharma, Inc. (TBPH) | 06-Mar-17 | Sale | 13,576 | $31.52 | $427,916.00 | (8%) 177.47K to 163.9K | |
| 22-Feb-17 7:06 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Feb-17 | Payment of Exercise | 14,434 | $33.78 | $487,580.00 | (8%) 191.91K to 177.47K | |
| 08-Feb-17 7:06 PM View: | Theravance Biopharma, Inc. (TBPH) | 06-Feb-17 | Grant | 9,000 | -- | -- | 5% 182.91K to 191.91K | |
| 22-Nov-16 6:02 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Nov-16 | Payment of Exercise | 5,388 | $31.96 | $172,200.00 | (3%) 188.29K to 182.91K | |
| 25-Aug-16 7:34 PM View: | Theravance Biopharma, Inc. (TBPH) | 25-Aug-16 | Sale | 4,491 | $27.99 | $125,703.00 | (2%) 192.78K to 188.29K | |
| 23-Aug-16 7:23 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Aug-16 | Payment of Exercise | 4,607 | $27.89 | $128,489.00 | (2%) 197.39K to 192.78K | |
| 23-Aug-16 7:23 PM View: | Theravance Biopharma, Inc. (TBPH) | 19-Aug-16 | Sale | 9,509 | $27.97 | $265,967.00 | (5%) 206.9K to 197.39K | |
| 24-May-16 7:59 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-May-16 | Payment of Exercise | 4,608 | $20.55 | $94,694.40 | (2%) 211.51K to 206.9K | |
| 17-Mar-16 7:08 PM View: | Theravance Biopharma, Inc. (TBPH) | 15-Mar-16 | Grant | 90,000 | -- | -- | 74% 121.51K to 211.51K | |
| 23-Feb-16 7:56 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Feb-16 | Payment of Exercise | 18,425 | $15.65 | $288,351.00 | (13%) 139.93K to 121.51K | |
| 24-Nov-15 7:36 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Nov-15 | Payment of Exercise | 781 | $17.17 | $13,409.80 | (< 1%) 140.71K to 139.93K | |
| 09-Feb-15 7:27 PM View: | Theravance Biopharma, Inc. (TBPH) | 05-Feb-15 | Grant | 135,000 | -- | -- | 2363% 5.71K to 140.71K |